HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 293 filers reported holding HAEMONETICS CORP in Q2 2018. The put-call ratio across all filers is 13.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $524,000 | -5.2% | 4,559 | +3.9% | 0.00% | 0.0% |
| Q3 2019 | $553,000 | +76.7% | 4,386 | +69.2% | 0.00% | +100.0% |
| Q2 2019 | $313,000 | -33.8% | 2,592 | -52.1% | 0.00% | -50.0% |
| Q1 2019 | $473,000 | +133.0% | 5,414 | +167.8% | 0.00% | +100.0% |
| Q4 2018 | $203,000 | +534.4% | 2,022 | +614.5% | 0.00% | – |
| Q3 2018 | $32,000 | +28.0% | 283 | +2.2% | 0.00% | – |
| Q2 2018 | $25,000 | -69.1% | 277 | -75.2% | 0.00% | -100.0% |
| Q1 2018 | $81,000 | +22.7% | 1,115 | -1.7% | 0.00% | 0.0% |
| Q4 2017 | $66,000 | +29.4% | 1,134 | -0.8% | 0.00% | 0.0% |
| Q3 2017 | $51,000 | +6.2% | 1,143 | -6.1% | 0.00% | 0.0% |
| Q2 2017 | $48,000 | +2.1% | 1,217 | +4.2% | 0.00% | 0.0% |
| Q1 2017 | $47,000 | +2.2% | 1,168 | +1.2% | 0.00% | 0.0% |
| Q4 2016 | $46,000 | -19.3% | 1,154 | -26.6% | 0.00% | 0.0% |
| Q3 2016 | $57,000 | +18.8% | 1,572 | -7.0% | 0.00% | 0.0% |
| Q2 2016 | $48,000 | – | 1,690 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
| Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
| Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
| Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
| Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
| AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
| Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
| Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
| TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
| AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |